Statin use and risk for ovarian cancer: a Danish nationwide case-control study

L Baandrup, C Dehlendorff, S Friis, J H Olsen, S K Kjær

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

    Abstract

    BACKGROUND: Limited data suggest that statin use reduces the risk for ovarian cancer.

    METHODS: Using Danish nationwide registries, we identified 4103 cases of epithelial ovarian cancer during 2000-2011 and age-matched them to 58,706 risk-set sampled controls. Conditional logistic regression was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for epithelial ovarian cancer overall, and for histological types, associated with statin use.

    RESULTS: We observed a neutral association between ever use of statins and epithelial ovarian cancer risk (OR=0.98, 95% CI=0.87-1.10), and no apparent risk variation according to duration, intensity or type of statin use. Decreased ORs associated with statin use were seen for mucinous ovarian cancer (ever statin use: OR=0.63, 95% CI=0.39-1.00).

    CONCLUSIONS: Statin use was not associated with overall risk for epithelial ovarian cancer. The inverse association between statin use and mucinous tumours merits further investigation.

    OriginalsprogEngelsk
    Sider (fra-til)157-61
    Antal sider5
    TidsskriftBritish Journal of Cancer
    Vol/bind112
    Udgave nummer1
    DOI
    StatusUdgivet - 6 jan. 2015

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Statin use and risk for ovarian cancer: a Danish nationwide case-control study' indeholder.

    Citationsformater